YCBD Stock Earnings cbdMD Beats EPS, Beats Revenue for Q3 2024
| YCBD Stock | USD 0.49 0.02 3.92% |
About 61% of CbdMD's investor base is looking to short. The analysis of overall sentiment of trading cbdMD Inc stock suggests that many investors are alarmed at this time. The current market sentiment, together with CbdMD's historical and current headlines, can help investors time the market. In addition, many technical investors use cbdMD Inc stock news signals to limit their universe of possible portfolio assets.
CbdMD |
YCBD stock results show that cbdMD beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024.
Read at investorplace.com
 |
CbdMD Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards CbdMD can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
CbdMD Fundamental Analysis
We analyze CbdMD's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CbdMD using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CbdMD based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Earnings Per Share
Earnings Per Share Comparative Analysis
CbdMD is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
cbdMD Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with CbdMD stock to make a market-neutral strategy. Peer analysis of CbdMD could also be used in its relative valuation, which is a method of valuing CbdMD by comparing valuation metrics with similar companies.
Peers
CbdMD Related Equities
| CPHI | China Pharma | 5.26 | ||||
| SBFM | Sunshine Biopharma | 4.76 | ||||
| TKNO | Alpha Teknova | 1.63 | ||||
| GRUSF | Grown Rogue | 1.52 | ||||
| TCNNF | Trulieve Cannabis | 1.63 | ||||
| GTBIF | Green Thumb | 2.21 | ||||
| SXTC | China SXT | 2.44 | ||||
| SNOA | Sonoma Pharmaceuticals | 4.45 | ||||
| CURLF | Curaleaf Holdings | 4.46 | ||||
| PTPI | Petros Pharmaceuticals | 6.90 |
Complementary Tools for CbdMD Stock analysis
When running CbdMD's price analysis, check to measure CbdMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CbdMD is operating at the current time. Most of CbdMD's value examination focuses on studying past and present price action to predict the probability of CbdMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CbdMD's price. Additionally, you may evaluate how the addition of CbdMD to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Global Correlations Find global opportunities by holding instruments from different markets |